|

JS111 capsules (AP-L1898) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Suzhou Junjing BioSciences Co., Ltd.1

Indications

  • NSCLC1
  • Lung Cancer1
  • Cancer1

Other1 trial

JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.